Rosuvastatin Completed Phase 4 Trials for Type 2 Diabetes Mellitus Prevention

IndicationsStatusPurposePhase
CompletedPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT03784703Type 2 Diabetic Patients Maintained on Statin Therapy